key: cord-1056551-k06mxb0m
authors: Graber, Tyson E.; Mercier, Élisabeth; Bhatnagar, Kamya; Fuzzen, Meghan; D'Aoust, Patrick M.; Hoang, Huy-Dung; Tian, Xin; Towhid, Syeda Tasneem; Diaz, Julio Plaza; Eid, Walaa; Alain, Tommy; Butler, Ainslie; Goodridge, Lawrence; Servos, Mark; Delatolla, Robert
title: Near real-time determination of B.1.1.7 in proportion to total SARS-CoV-2 viral load in wastewater using an allele-specific primer extension PCR strategy
date: 2021-09-23
journal: Water Res
DOI: 10.1016/j.watres.2021.117681
sha: 4af012ab8ec6a927d379673d6da8ec555291ddfa
doc_id: 1056551
cord_uid: k06mxb0m

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed millions of lives to date. Antigenic drift has resulted in viral variants with putatively greater transmissibility, virulence, or both. Early and near real-time detection of these variants of concern (VOC) and the ability to accurately follow their incidence and prevalence in communities is wanting. Wastewater-based epidemiology (WBE), which uses nucleic acid amplification tests to detect viral fragments, is a reliable proxy of COVID-19 incidence and prevalence, and thus offers the potential to monitor VOC viral load in a given population. Here, we describe and validate a primer extension PCR strategy targeting a signature mutation in the N gene of SARS-CoV-2. This allows quantification of B.1.1.7 versus non-B.1.1.7 allele frequency in wastewater without the need to employ quantitative RT-PCR standard curves. We show that the wastewater B.1.1.7 profile correlates with its clinical counterpart and benefits from a near real-time and facile data collection and reporting pipeline. This assay can be quickly implemented within a current SARS-CoV-2 WBE framework with minimal cost; allowing early and contemporaneous estimates of B.1.1.7 community transmission prior to, or in lieu of, clinical screening and identification. Our study demonstrates that this strategy can provide public health units with an additional and much needed tool to rapidly triangulate VOC incidence/prevalence with high sensitivity and lineage specificity.

Since the start of the COVID-19 pandemic, the possibility of SARS-CoV-2 antigenic drift, whereby genetic mutation gives rise to more transmissible and/or virulent viruses was identified as a potential risk to public health (Pachetti et al., 2020) . SARS-CoV-2, being a single-stranded RNA (ssRNA) virus, is susceptible to frequent mutation (Duffy, 2018; Holmes and Rambaut, 2004; Kustin and Stern, 2021; Sanjuán et al., 2010) . Generally, most viral mutations have a low impact on disease in populations , but in late 2020, several concurrent mutations emerged in circulating SARS-CoV-2 genomes which increase infectivity (Chen et al., 2020; Korber et al., 2020) and potentially decrease sensitivity to neutralizing antibodies (Gaebler et al., 2021; Wang et al., 2021) . As of May 2021, these variants of concern (VOC) as declared by the WHO include B.1.1.7 (α), B.1.351 (β), P.1 (γ), and B.1.617.2 (δ) (Konings et al., 2021) . With communities around the world already reeling from the effects of the initial pandemic waves, the putative increase in morbidity and mortality associated with VOC infection relative to that of earlier variants, is affecting the resilience of health care systems and communities.

SARS-CoV-2 wastewater-based epidemiology (WBE) is being adopted as a means of surveillance in many jurisdictions around the world (reviewed in (Hamouda et al., 2021) ). The common method currently used to detect fragments of SARS-CoV-2 viral RNA in wastewater is qRT-PCR utilizing hydrolysis probe and primer sets that were validated for clinical testing (Vogels et al., 2020) . The high specificity and sensitivity of the CDC "2019-nCoV N1" (N1) and "2019-nCoV N2" (N2) probe/primer sets seen in clinical samples (Vogels et al., 2020) , appear to be mirrored in wastewater matrices (Hamouda et al., 2021) although relative sensitivities between the sample types haven't been formally investigated. N1 and N2 assays are thus used by many WBE research groups including those participating in the provincial wastewater surveillance initiative in Ontario, Canada. Critically, these qRT-PCR assays currently do not distinguish VOCs. Here, we describe and validate a qRT-PCR assay that targets a B.1.1.7-specific allele that lies adjacent to the N1 region and which employs new forward primers along with the existing N1 probe and reverse primer. This assay uses an allele-specific primer extension strategy capable of discriminating single nucleotide variants in a pooled sample such as wastewater. As such, this strategy can be employed to detect other VOCs as they emerge.

24-hour composite samples of primary clarified sludge (PCS) were collected from the Ottawa, Ontario Both sampled WRRFs are designed and operated as conventional treatment trains with influent entering screens and flowing to grit chambers followed by primary clarifiers and then activated sludge units. WRRF characteristics are outlined in Table 1 .

Population serviced (approx. number of inhabitants) 1,000,000 135,000

Average ( Barrie. The population serviced and average daily and peak design flow rates in million litres per day 7 (MLD) are indicated together with annual average influent concentrations of total suspended solids (TSS), carbonaceous biological oxygen demand (cBOD 5 ), ammonia-nitrogen (NH 3 -N) and total phosphorus (TP).

The solids in influent collected at the Barrie, Ontario WRRF were first allowed to settle at 4°C for one hour prior to decanting. Settled influent solids or PCS samples collected at Barrie or Ottawa WRRFs were well-mixed and 40 ml transferred to a 50 mL round-bottom centrifuge tube. Samples were centrifuged at 10,000 x g in a fixed angle rotor for 45 minutes at 4°C. The supernatant was discarded, taking care not to disturb the pellet. Samples were centrifuged a second time at 10,000 x g for 5 minutes and the remaining supernatant decanted. The resulting pellets were transferred to a RNase-free microfuge tube, the tared weight was recorded, and the RNA was immediately extracted. Total RNA was extracted using the RNeasy PowerMicrobiome Kit (Qiagen, Germantown, MD) on a QIAcube Connect automated extraction platform, with a modified protocol. The following changes to the manufacturer's protocol were performed: 1) 250 ± 15 mg of sample pellet was added to the initial extraction step in place of 200 µL of liquid sample, and 2) the optional phenol-chloroform step was instead performed with Trizol LS reagent (ThermoFisher, Ottawa, Canada) prior to vortexing and centrifugation. The resulting aqueous phase was retained and processed as per the original manufacturer's protocol and included the DNase treatment step. RNA was eluted in 100 µl of RNase-free water. qRT-PCR reactions were run in triplicate using 1.5 µl of RNA input in a final reaction volume of 10 μl.

Cycling was performed on a CFX Connect qPCR thermocycler (Bio-Rad, Hercules, CA) as follows: RT at 50ºC, 5 minutes, followed by RT inactivation, polymerase activation and template denaturation at 95ºC for 20 seconds, and 45 cycles of denaturation (95ºC/3s), then annealing/extension (55ºC/45s µL of supermix, 2 µL of reverse transcriptase, 1 µL of DTT, and PCR-grade water to make up the balance of the 20 µL reaction. The droplet generation, PCR reaction, quantification and data analysis was carried out as described in an earlier study (D'Aoust et al., 2021a) .

To identify a signature mutation that is a good candidate for a single locus, B.1.1.7-specific qRT-PCR assay, we used the global GISAID clinical SARS-CoV-2 genomic database (Elbe and Buckland-Merrett, 2017) to probe for amino acid mutations that were present in >95% of B.1.1.7 sequences and with <0.1% prevalence in other lineages. This was accomplished by manually surveying nucleotide mutation tables across GISAID sequences categorized by Pango lineage using covidcg.org . We then confirmed and visualized these findings by generating radial plots from subsampled GISAID sequences using nextstrain.org (Hadfield et al., 2018) . Specifically, radial plots of amino acidand nucleotide-level genomic loci were generated using the global database which subsampled 3799 GISAID SARS-CoV-2 sequences on February 12, 2021.

To compare our wastewater findings to the local clinical picture, we obtained case data from 

Spearman's rank correlation was determined between D3L wastewater allele frequency and clinical case proportion over time. A two-tailed Student's t-test was used to determine significance of the correlation relative to the null hypothesis of zero correlation. Both were calculated in the "Analysis:Correlation" dialogue within GraphPad Prism v. 9.1.2 for Mac OS (Motulsky, 2021) . Radial plots were generated on nextstrain.org (Hadfield et al., 2018) . Other plots were generated with GraphPad

Prism v. 9.1.2 for Mac OS.

The proportion of SARS-CoV-2 RNA signal in wastewater that can be attributed to D3L allelesthe D3L allele frequencywas determined based on equivalent primer efficiencies and y-intercepts (i.e., assay sensitivities) observed for both D3 and D3L standard curves. These equivalent assay properties allow direct comparison of Ct values that fall along the qRT-PCR standard curves derived from RNA templates. Thus, a perceived advantage of this method is that it doesn't require absolute quantification via standard curves to determine the B.1.1.7-specific (D3L) signal as a proportion of the total SARS-CoV-2 .

Clinical diagnosis of a B.1.1.7 case, with its multiple mutations, requires a highly specific assay with a very high positive predictive value. This is difficult to achieve in a singleplex qRT-PCR assay, as targeting multiple, co-occurring mutations at different loci may be needed to unambiguously define a VOC. Multiplexed assays or secondary screens incorporating Sanger sequencing and/or whole-genome sequencing are therefore required to confirm the genetic lineage of a virus isolated from clinical specimens("PHO VOC testing descriptions," 2021). Unlike testing of individuals, wastewater samples include genomes (and fragments thereof) sourced from multiple infections and can be collected at high frequency (e.g., daily) over continuous periods. The additional longitudinal granularity provided by wastewater sampling allows passive, population-level probing of COVID-19 infection courses. This property provides substantial power to probe and follow the dynamics of allele frequencies in a population as infections wax and wane.

We hypothesized that following a single, signature mutation in this context would yield sufficient power to distinguish VOC lineages. This is because other variants carrying a mutation at the same locus are likely to be rare and below detection limits as they are believed to be less transmissible and thus have a very low prevalence which does not change over time ( Figure 1A) . We found that one such signature mutation on the N gene at the amino acid level (D3L) is present in the B.1.1.7 lineage ( Figure 1B) . Figure 1D ). This allele-specific primer extension strategy works by virtue of the inability of DNA polymerase to extend mismatched nucleotides at the 3' end of the primer (Lefever et al., 2013) . This method affords high allele specificity, while obviating the complexities and high cost associated with the development of competition probe assays. We then combined this forward primer with the existing N1 probe and reverse primer ( Figure 1D , and Materials and Methods).

We call these two new assays "D3" and "D3L",distinguishing non-B.1.1.7 from B.1.1.7 viral lineages, respectively, when applied in the wastewater context. Coincident with the development of the assay described in this work, Lee et al also demonstrated the feasibility of the allele-specific primer extension strategy to monitor VOC mutations in wastewater with assays designed to detect 3 different mutations on the SARS-CoV-2 S protein (Lee et al., 2021) . Additional VOC-specific qRT-PCR assays, such as those that are based on allele-specific competition probes have also been described and validated in wastewater samples (Peterson et al., 2021) While the strategy of using a single genomic locus signature might give sufficient resolution in the wastewater context, it is important to note that this assay may not have a high specificity in clinical samples for viruses of the B.1.1.7 lineage as a rare mutation may occur at this location in individual cases. Another caveat of the proposed assay is that emerging viral variants might accumulate additional mutations in the probe and primer region of the assay that would affect sensitivity. Indeed, partway into designing and testing this new assay at the end of December 2020 when B.1.1.7 was becoming prevalent in the United Kingdom, we noted the emergence of a SNV in B.1.1.7 sequences deposited at GISAID that co-occurred with the D3L mutation and is located in the middle of the D3L forward primer. This deletion mutant (A28271del) quickly became the dominant SNV in the B.1.1.7 lineage, co-occurring with D3L at similar frequencies in the United Kingdom ( Figure 1D) . The D3L forward primer used in this study therefore incorporates this SNV. Together, this design strategy (i.e., targeting a signature mutation that lies close to existing sensitive qPCR probe/primer sets) has the potential to create specific and sensitive qRT-PCR assays for determining the proportion of VOC-specific RNA signal in wastewater samples. 

We performed D3L, D3 and N1 qRT-PCR assays on serial dilutions of B.1.1.7 or Lineage B

(Wuhan-Hu-1) in vitro transcribed RNA templates obtained from a commercial supplier (Twist Bioscience, San Francisco, CA) to generate standard curves (Figure 2A, B) . To compare similar template inputs, we determined the copy number (cp) of the RNA templates based on N1 RT-ddPCR (indicated in Figures   2A, B and S1 ). qRT-PCR for N1 exhibited excellent efficiency (>98%) and analytical sensitivity (4/4 wells detected) down to ~5 cp with either the B.1.1.7 or Lineage B templates (Figure 2A, B) , consistent with our previous data (D'Aoust et al., 2021b) and that of others (Ahmed et al., 2021) . Importantly, both D3L

and D3 assays on their respective complementary RNA templates demonstrated excellent efficiency (98.1 and 98.4%), linearity (96 and 99%), and analytical sensitivity (4/4 wells detected) comparable to N1, although y-intercepts tended to be approximately 2 cycles higher, indicating that the limit of detection for D3 and D3L is higher than N1 under these conditions. 14 An allele-specific assay must be able to discriminate the targeted alleles without cross-talk (i.e., it must not amplify the non-targeted allele). To this end, we assessed the D3L and D3 assays on serial dilutions of their orthogonal templates (Lineage B and B.1.1.7, respectively, Figure 2A, B) . We observed excellent allele specificity, with no detectable cross-talk (no amplification at 45 cycles) until template copy number approached 300 (Ct~31) at which point weak detections were observed (differences of 8-10 cycles between complementary and orthogonal templates; compare ΔCt in Figure 2A, B) . Importantly, this cycle difference was maintained when template copies were an order of magnitude higher. To independently confirm our observations, the laboratory of Dr. Mark Servos, a participant in the Ontario Wastewater Surveillance Initiative assessed the D3 and D3L primer efficiencies and analytical sensitivity on the same RNA templates but using a different one-step qRT-PCR supermix and found similar performance ( Figure S1 ).

We next assessed the sensitivity and specificity of the D3L assay by probing fecal RNA extracted from COVID-19 hospital patients that had been admitted in Fall 2020 to the Ottawa Hospital, prior to the introduction of B.1.1.7 into the community. SARS-CoV-2 RNA isolated from human feces could be partially degraded/fragmented and contains both sub-genomic (sg) and genomic (g) RNAs. The D3L and D3 forward primers span an intergenic region of the genome and the two 5' terminal nucleotides of the forward primers are a mismatch for the leader sequence that is present on intact N sgRNA transcripts ( Figure 1D) . Thus, D3L and D3 qRT-PCR sensitivity may be lower in viral RNA extracted from COVID-19 patient feces compared to N1. Although we readily detected N1 amplicons (Ct~33) in COVID-19 patient feces (pooled from 2 patients), we observed that D3 signal in the same sample was ~30% of N1 ( Figure   2C ). Critically, we did not observe any amplification of the D3L allele in patient feces after 45 cycles, consistent with the allele-specificity observed with the synthetic RNA template and the putative B.1.1.7negative status of the patients (Figure 2C ). Using N1 to normalize any RT and/or PCR inhibition that might be present in RNA extracted from feces, we compared D3 sensitivity in patient fecal RNA vs. that obtained from IVT RNA. Comparing the difference in Cts (ΔCt) between D3 and N1 signals (Figure 2D ), we found that the D3 assay was approximately 50% less sensitive (amplified ~1 cycle later) with a fecallyextracted vs. IVT viral RNA template. Although this data was derived from a single pooled fecal sample from two patients, it nonetheless suggests some form of RT and/or PCR inhibition that is specific to the 15 D3 assay (as we are controlling for general RT and/or PCR inhibition by normalizing to N1 which shares a common probe and reverse primer with the D3 assay). This could be due to a number of properties that are inherent to the fecal matrix including: 1) increased competition from other RNAs present, 2) increased D3 RNA fragmentation, 3) sgRNA-derived cDNAs that are amplified less efficiently due to mismatches at the 5' end of the forward primer, 4) Impaired reverse transcription of the D3 region, or 5) PCR inhibitors that differentially affect D3 cDNA amplification. Further investigation is needed to understand this phenomenon. Together, these data demonstrate the sensitivity and allelic specificity of D3L and D3 assays in COVID-19 patient fecal samples and support the applicability of this assay to the wastewater context. 

We obtained 24h composite influent and grab primary sludge samples (n=1 for each sample type) collected on January 26, 2021 from a WRRF serving the mid-size (pop. ~135K) community of Barrie,

Ontario. More than two weeks prior to sampling, on January 8, a COVID-19 outbreak was declared at a long-term care facility (LTCF) within the WRRF catchment. More than 100 B.1.1.7 cases associated with this outbreak were later confirmed by whole genome sequencing of clinical samples at the provincial laboratories. Most cases were likely active at the time of sampling ( Figure 3A) . We readily detected N1 amplicons in both samples, indicating that SARS-CoV-2 was prevalent in the community at the time of sampling and served as a positive control ( Figure 3B ). Critically both samples from Barrie yielded detectable signal with the D3L assay ( Figure 3B) . D3, targeting non-B.1.1.7 was at very low levels compared to D3L. Given that primer efficiencies of D3 and D3L are virtually identical (Figure 2A, B) , this allowed us to estimate their relative abundance and suggested that B.1.1.7 was the dominant viral lineage in the community at the time of sampling. To assess the sensitivity and specificity of the D3L assay in a background of non-B.1.1.7 SARS-CoV-2 in a wastewater context, we sampled a 24h

composite of primary sludge obtained on January 16, 2021, from a wastewater resource recovery facility (WRRF) serving a large Canadian urban center (Ottawa, Ontario; pop. ~1M). Although we could detect both N1 and D3 alleles, the D3L assay failed to detect B.1.1.7-specific RNA fragments ( Figure 3B ).

According to Ottawa Public Health, fewer than 5 clinically verified and travel-related B.1.1.7 cases were active in this community at the time of the wastewater sampling.

To validate the D3L qRT-PCR assay, we sent the same Barrie raw influent sample to be sequenced at the National Microbiology Laboratory (NML) in Winnipeg, Manitoba. In a companion report, by Landgraff et al, a consensus metagenome was sequenced from this sample that was consistent with viruses of the B.1.1.7 lineage, thus confirming both our qRT-PCR data and the contemporaneous clinical landscape in the community (Landgraff et al., 2021) .

Passive and near-real-time monitoring tools to assess disease incidence and prevalence within communities and across larger political jurisdictions have transformative potential for public health. In the context of the current pandemic where an already highly transmissible respiratory virus has undergone antigenic drift that has led to higher attack rates, rapid intelligence and action is required to effectively curtail new outbreaks. Where the immunized predominate, breakthrough events resulting from infections with emerging viral variants must be rapidly identified. Clinical COVID-19 surveillance of populations continues to be hampered in many parts of the world due to low resources and inadequate supply chain networks (Vandenberg et al., 2021) . Even in jurisdictions with excellent clinical surveillance systems, socioeconomic barriers and hesitancy to testing make it difficult for epidemiologists and governments to maintain a clear picture of COVID-19 in their communities (Rubin, 2020) . Complementary approaches are therefore highly desirable.

We aimed to assess the feasibility of quantifying the proportion of SARS-CoV-2 RNA signal in wastewater that can be attributed to a VOC in a community using the D3L/D3 assays. Twice weekly measurements for N1, D3L and D3 in Ottawa primary sludge were undertaken beginning February 21, 2021. N1 served as a VOC-agnostic positive control. We did not reliably detect (>1 of 3 replicates under 40 Cts) D3L alleles until March 2, 2021 at which point we computed the D3L allele frequency making up the total SARS-CoV-2 allelic signature in wastewater; a ratio of D3L (B.1.1.7) signal to total SARS-CoV-2 signal (D3+D3L). See Materials and Methods for more detail. Additional non-detects were observed until the middle of March at which point D3L allele concentrations consistently increased and with which we were able to calculate allele frequencies (Figure 3C, top) . To quantify the functional sensitivity of the D3/D3L vs. N1 assays in situ (i.e., the relative ability to detect fecally shed viral RNA fragments present in the primary sludge) vs. analytical sensitivity derived in vitro (i.e., on synthetic RNA template) we measured the distribution of N1 as well as the sum of D3 and D3L signals, the latter of which is an estimate of the total signal from this genomic locus in wastewater. We observed a nearly 1 log difference in the mean of the two distributions (Figure S2A) , indicating that amplification from the D3 and D3L loci is significantly impaired in the wastewater context compared to that on synthetic RNA or template extracted 18 from patient feces. Possible explanations include differential inhibition of RT and/or PCR, increased fragmentation in the locus targeted by the forward primers, increased competition of forward primers for other nucleic acid templates, or the fact that they overlap an intergenic region that might differentially detect genomic vs. sub-genomic RNA concentrations.

We next determined if the D3L allele frequency observed in wastewater correlated with VOCspecific clinical surveillance efforts. SARS-CoV-2 genomic surveillance in Ontario could not process the volume of cases during the Winter and Spring COVID-19 waves in Ottawa which precluded unbiased sampling and reporting. The SARS-CoV-2 case distribution across this period (January-April, 2021) in

Ottawa is shown in grey in Figure 3C , bottom. Coincident with our assay development in (Figure 3C, bottom) . Note the significant time-lag in clinical VOC reporting (approx.10 days; denoted by the orange shaded regions in Figure 3C ) due to bottlenecks in the primary and secondary screening of nasopharyngeal swabs, due to both lab and data entry delays during a period of high disease incidence in the community (personal communication, Ottawa Public Health).

We calculated the proportion of N501Y + (N501Y + + N501Y + /E484 -+ N501Y + /E484K + ) cases relative to all cases and plotted this based on episode date (Figure 3C, top) to case proportion in the study window ( Figure S2B) . Thus, considering all N501Y + cases derived from both singleplex and duoplex testing simplified our analysis and interpretation. A cursory examination

shows that the distribution of clinical N501Y + case proportion generally followed that of the wastewater D3L allele frequency over time (Figure 3C, top) Figure 3D ). During the initial phase of the B.1.1.7 epidemic in Ottawa, when clinical cases were low, the wastewater assay had insufficient sensitivity leading to 11 non-detect observations between January 16 and March 20. These zero values skew the distribution, and we therefore repeated our correlation analysis, omitting the non-detected observation pairs ( Figure 3E ). This 2 nd analysis also showed a strong correlation that deviates significantly from zero (r s =0.714, p=0.008).

Finally, to again validate the reliability and specificity of the D3L qRT-PCR assay in reporting B.1.1.7 viral RNA in wastewater, an influent sampled collected at Ottawa WRRF on April 25, 2021 was sent for metagenomic sequencing to NML (timepoint indicated in Figure 3C ) (Landgraff et al., 2021) . As was seen with the Barrie sample, the Ottawa wastewater sample yielded a consensus B.1.1.7 metagenome. 2021, prior to the clinical reporting lag, were included from the data presented in (C). A line of regression was computed, and Spearman's rank correlation coefficient (r s ) is indicated. A two-tailed t-test indicated this correlation deviated significantly from zero. (E) Analysis as in (D), but with wastewater qRT-PCR nondetects omitted (n=13). A significant correlation was still observed.

These data support the use of wastewater-based allele-specific qRT-PCR strategies to follow the emergence and proportion of VOC-specific RNA signal that makes up total wastewater SARS-CoV-2 RNA signal in populations served by WRRFs. We demonstrate that an allele-specific qRT-PCR assay targeting a single locus on the SARS-CoV-2 genome can provide sufficiently high lineage specificity and detection sensitivity in the wastewater context. We also demonstrate good correlation between two independent measures of VOC (B.1.1.7) infection in a population, namely clinical case proportion and wastewater allele frequency, which together can be used to triangulate incidence and prevalence of VOCspecific infections. The latter method to monitor VOC appears less susceptible to data inaccuracies and bottlenecks associated with scaling that occurs during times of elevated disease incidence in the community. Moreover, the flexibility of this proxy measure of COVID-19 incidence allows rapid and parallel implementation of multiple assays targeting other VOC-specific alleles within existing WBE surveillance architectures. In conclusion, our study demonstrates that targeting signature mutations in the N gene with allele-specific primer extension qRT-PCR represents a viable strategy to quantitatively monitor emerging VOC in wastewater over time with high sensitivity, specificity, and speed.

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

The authors have no competing financial interests. 

Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: A surveillance tool for assessing the presence of COVID-19 infected travellers

Covid-19 cg enables sars-cov-2 mutation and lineage tracking by locations and dates of interest

Mutations Strengthened SARS-CoV-2 Infectivity

COVID-19 wastewater surveillance in rural communities: Comparison of lagoon and pumping station samples

Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence

Catching a resurgence: Increase in SARS-CoV-2 viral RNA 24 the

Why are RNA virus mutation rates so damn high?

Data, disease and diplomacy: GISAID's innovative contribution to global health

Evolution of antibody immunity to SARS-CoV-2

We shouldn't worry when a virus mutates during disease outbreaks

NextStrain: Real-time tracking of pathogen evolution

Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications

Viral evolution and the emergence of SARS coronavirus

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Biased Mutation and Selection in RNA Viruses

Metagenomic sequencing of municipal wastewater provides a near-complete SARS-CoV-2 genome sequence identified as the B.1.1.7 variant of concern from a Canadian municipality concurrent with an outbreak

Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays

Graphpad Statistics Guide: Spearman Rank Correlation and t-test

Ontario Wastewater Surveillance Initiative

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

RT-qPCR detection of SARS-CoV-2 mutations S 69-70 del, S N501Y and N D3L associated 1 with variants of concern in Canadian wastewater samples 2 3 Authors

PHO VOC testing descriptions

Medical News & Perspectives First It Was Masks; Now Some Refuse Testing for SARS-CoV-2

Viral Mutation Rates

Considerations for diagnostic COVID-19 tests

Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

A radial plot of mutations amongst globally sampled GISAID SARS-CoV-2 sequences at the N:D3 locus. The D3L mutation is a signature of the B.1.1.7 lineage. (C) A radial plot as in B but at the nucleotide level showing that the T28282A

D3 which amplifies alleles other than the B.1.1.7-specific allele (NOT B.1.1.7), and D3L which target B.1.1.7-specific alleles. The D3L primer also incorporates a deletion at A28271 which is present in the vast majority of B.1.1.7 genomes. TRS-B=Transcriptional regulatory site-body. Radial plots were generated on nextstrain

Standard curve of N1, D3L, and D3 assays performed with serial dilutions of a synthetic B.1.1.7 genomic RNA template (GISAID accession ID EPI_ISL_710528, Twist Biosciences). (B) Standard curve of N1, D3L, and D3 assays performed with serial dilutions of a synthetic non-B1.1.7 genomic RNA template (Wuhan-Hu-1 isolate). For both standard curves, N1 RNA copy number (cp) determined by RT-ddPCR is indicated. In panels (A) and (B), error bars represent the standard deviation of the mean of 4 qRT-PCR replicates. Calculated primer efficiencies ([10-1/m -1]*100), linear fit, and equation of the line of regression are indicated for D3L (A) and D3 (B). (C) The B.1.1.7 allele (D3L) is not detectable in RNA extracted from the pooled feces of 2 human COVID-19 patients admitted to an Ottawa hospital prior to the emergence of B.1.1.7 in Canada

B) Amount of alleles in wastewater determined by qRT-PCR and expressed as linearly transformed Ct values (2-Ct). Raw Ct values are indicated on the right axis. N1, D3, D3L assays were performed on raw influent solids or primary sludge samples collected from WRRFs in i)

Mean of qRT-PCR replicates (n=3) from each of the 3 indicated samples is presented with error bars representing s.d. (C, top) The proportion of N501Y+ clinical cases from all tested SARS-CoV-2 cases by episode date compared to D3L allele frequency in wastewater. Trend lines represent 7-day midpoint rolling averages

See text for details. (C, bottom) SARS-CoV-2 case distributions in Ottawa, Ontario by episode date and assigned genotypes. Cases initially screened positive by qRT-PCR (SARS-CoV-2) were subsequently screened using qRT-PCR assays targeting either N501Y beginning in February, or N501Y/E484K beginning in March. The estimated reporting lag period between the time a case is detected and the reported results of the N501Y/E484K assay is indicated by the yellow shaded region. Clinical data were provided by Ottawa Public Health and Simcoe Muskoka District Health Unit

A line of regression was computed, and Spearman's rank correlation coefficient (rs) is indicated. A two-tailed t-test indicated this correlation deviated significantly from zero. (E) Analysis as in (D), but with wastewater qRT-PCR nondetects omitted (n=13)

The authors wish to acknowledge the leadership of Dr. Alex MacKenzie (CHEO-RI) in this continuing endeavour. We are grateful to Dr. Chrystal Landgraff and her team at National Microbiology Laboratory for performing the metagenomic sequencing and to Dr. Kyrylo Bessonov and Mr. CameronMcDermaid for their helpful comments in reviewing the manuscript. The authors acknowledge the crucial participation and fruitful collaborations with Water Services at the Cities of Ottawa and Barrie; public health agencies (Ottawa Public Health, Simcoe Muskoka District Public Health Units, Public Health Ontario), along with funding provided through the Ontario Wastewater Surveillance Initiative("Ontario Wastewater Surveillance Initiative," n.d.). Their respective employees' time, facilities, resources, and assistance provided throughout the study greatly contributed to this work. We gratefully acknowledge the originating and submitting laboratories responsible for sharing genetic sequence data via the GISAID Initiative, which was used in this project.